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Abstract
The prediction of antibody-protein (antigen) interactions is very difficult due to the huge variability that characterizes the
structure of the antibodies. The region of the antigen bound to the antibodies is called epitope. Experimental data indicate
that many antibodies react with a panel of distinct epitopes (positive reaction). The Challenge 1 of DREAM5 aims at
understanding whether there exists rules for predicting the reactivity of a peptide/epitope, i.e., its capability to bind to
human antibodies. DREAM 5 provided a training set of peptides with experimentally identified high and low reactivities to
human antibodies. On the basis of this training set, the participants to the challenge were asked to develop a predictive
model of reactivity. A test set was then provided to evaluate the performance of the model implemented so far. We
developed a logistic regression model to predict the peptide reactivity, by facing the challenge as a machine learning
problem. The initial features have been generated on the basis of the available knowledge and the information reported in
the dataset. Our predictive model had the second best performance of the challenge. We also developed a method, based
on a clustering approach, able to ‘‘in-silico’’ generate a list of positive and negative new peptide sequences, as requested by
the DREAM5 ‘‘bonus round’’ additional challenge. The paper describes the developed model and its results in terms of
reactivity prediction, and highlights some open issues concerning the propensity of a peptide to react with human
antibodies.
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Introduction
Given their key role in the immune response, antibody-protein
interactions play a major role in a variety of clinical domains
(infectious diseases, autoimmune diseases, oncology, vaccination
and therapeutic interventions). For this reason, the prediction of
antibody-protein interactions can be of critical importance [1–2].
The antibodies have a wide range of heterogeneous structures
generated by genomic recombination: the number of human
antibodies is estimated to be around 10
10 and 10
12 [3]. The
antibodies interact with proteins (called antigens) through their
binding sites (called paratopes).
The region of the antigen bound with the paratope is called
epitope. Two types of epitopes are typically distinguished in
protein-antibody interaction studies: conformational and linear
epitopes. A linear/sequential epitope is recognized by its linear
sequence of amino acids (primary structure). In contrast, most
antibodies recognize conformational epitopes with a specific three-
dimensional structure.
All potential linear epitopes of a protein are short peptides that
can be synthesized and arrayed on solid supports, e.g. glass slides
[4]. By incubating these peptide arrays with antibody mixtures,
such as human serum or plasma, it is possible to determine specific
interactions between antibodies and peptides.
The binding site of a linear epitope has a typical length ranging
between 8 and 10 amino acids. An antibody binds to its epitope/
peptide independently of the physical position of the binding site
within the peptide. Every amino acid has a different impact on the
epitope reactivity; this is not only due to its physicochemical
properties but also to its interaction with the neighboring residues
within the whole peptide sequence.
It has been often assumed that a specific antibody selectively
binds to a specific sequence. However, experimental data indicate
that many antibodies bind to a panel of related (or even distinct)
peptides with different affinities. The open question is whether
there exist rules that enable the prediction of common peptide/
epitope sequences, which can be recognized by human antibodies.
In order to address this problem, the DREAM (Dialogue for
Reverse Engineering Assessments and Methods) Consortium
issued the Epitope-Antibody Recognition (EAR) Specificity
Prediction Challenge (Challenge 1). In the experimental work
leading to this challenge, 75534 peptides were incubated with
commercially available intravenous immunoglobulin (IVIg) frac-
tions. IVIg is a mixture of naturally occurring human antibodies
isolated from up to 100000 healthy individuals. From this dataset,
high-confidence negative and positive pools of peptides were
determined. Training and test datasets were assembled from these
peptide pools. The epitope-antibody recognition challenge consists
of determining whether each peptide in the test set belongs to the
positive or negative set starting from the data of the training set.
A so-called ‘‘bonus round’’ was proposed beside this main
challenge. It consists of generating ‘‘in-silico’’ a list of positive and
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from the ones contained in the training set. The lists provided by
the best performing teams will be subsequently experimentally
evaluated.
In the literature, epitope prediction has been focused
primarily on sequence-dependent methods based on various
amino acid properties, such as hydrophilicity, solvent accessi-
bility, secondary structure and others [5–16]. Several methods
based on machine learning approaches have been applied, too
[17]. They comprise hidden Markov models (HMM), artificial
neural networks (ANN) and support vector machines (SVM)
[18–22]. Machine learning methods have been frequently
coupled with the so-called scale-based approach; this approach
exploits one or more scales of amino acid properties to weight
each residues of the sequence of interest. In particular it has
been shown that the combination of different scales with several
machine learning algorithms have better performances than
single scale methods [23].
We coped with the DREAM challenge by resorting to a classical
supervised machine learning strategy with knowledge-based
feature construction. After the definition of the problem features,
we developed a logistic regression classifier that showed a very
good performance on the test set.
Moreover, we developed a new method for dealing with the
bonus round challenge and we generated a list of de-novo peptides
that will be further experimentally assessed.
Materials and Methods
Data sets
As mentioned in the introduction, one of the DREAM 5
challenges dealt with the prediction of the reactivity of peptides to
bind intravenous immunoglobulin (IVIg) antibodies. The chal-
lenge organizers made available a dataset that comprises
sequences of peptides, which either bind IVIg antibodies with
high affinity/avidity or not.
In particular 75534 peptides were incubated with commercially
available human IVIg fractions. A set of 6841 peptides with high
affinity was identified (positive set). From the same original set,
20437 peptides were identified showing no antibody binding
activity in any of the triplicate assays (negative set). Each of these
peptides is unique in terms of its amino acid sequence.
Most of these sequences are 15 amino acids long; however,
there are also sequences with different lengths (several of them
were 13 amino acids long, while a few were long 9, 16, 18, 20 and
21 amino acids).
A reactivity value was calculated for each peptide. The
reactivity values range from 1 to 65536. The reactivity of the
positive peptides ranges between 10000 and 65536, while this
value ranges from 1 to 1000 in the negative peptides case. The
training and test datasets were assembled from these two peptide
sets.
Training set. The training set contained 13638 peptides and
was created by selecting 3420 peptides from the positive set and
10218 peptides from the negative set. Two features of each peptide
were provided: the amino acid sequence and a measure of the
peptide reactivity to the IVIg antibodies. The predictive model of
the peptide reactivity was trained on this dataset.
Test set. The test set contained 13640 peptides and was
formed by grouping the remaining 3421 positive peptides and the
remaining 10219 negative peptides. Only the sequence of these
peptides was provided for the initial phase of the challenge, while
their class (positive or negative) was made available to us only
when the results of the challenge had been published.
Main challenge
The main challenge consists of determining whether peptide
reactivity with antibodies is strong or weak, i.e., whether a peptide
of the test set belongs to the positive or negative set. The goal is
therefore to exploit the training set to develop a predictive model,
taking into account the available information (e.g., the information
on amino acids and protein-protein interactions available in
biological databases). Participants are required to submit a ranked
list of the peptides in the test set, ordered according to the
predicted probability that the peptide belongs to the positive set
(predicted reactivity).
We have dealt with this challenge by applying a proper
supervised learning pipeline. The approach consisted in feature
selection, classification and cross-validation on the training set and
finally evaluation of the model on the test set. These steps followed
a crucial phase of knowledge-based construction of the initial set of
features.
In the following sub-sections, we will describe, step-by-step, the
procedure applied to develop and test the proposed predictive
model.
Feature construction. The construction of a proper set of
features is the most important step of the development of a
successful predictive model.
In particular, we considered two sets of features for every
peptide: the first set is computed from the peptide sequence, while
the second set is generated taking into account the entire training
set.
The values of all the features have been normalized between 0
and 1.
In order to generate the first set of features, we exploited
information about the peptides and the epitopes reactivity.
In more detail, we used the following peptide attributes:
1. The sequence length, i.e. the number of residues of the peptide.
2. The isoelectric point, computed by using the iterative method
described by Tiengo et al. [24].
3. The amino acid frequencies (24 features), calculated as the
occurrence of each amino acid along the peptide; the four
ambiguous amino acid B (asparagine or aspartic acid), X
(unspecified or unknown amino acid), Z (glutamine or glutamic
acid) and J (leucine or isoleucine) have also been considered.
As mentioned in the introduction, several approaches have been
used for epitope prediction; the so-called scale-based approach
exploited one or more scales of amino acid properties to weight
each residues of the sequence of interest [2,18,25–28]. The use of
multiple scales was essential to predict epitope location reliably, as
reported by Blythe et al. [29]. Therefore, we considered some of
the most promising amino acid properties reported in these
studies, by resorting to a set of widely used scales (i.e. the five scales
reported in Table 1) [9–13]:
1. The antigenicity was calculated as proposed by Kolaskar et al.
[9]. The frequency of the residue in antigenic determinants
(experimentally identified) was exploited to calculate the
antigenic propensity of each amino acid.
2. The accessibility was calculated on the basis of the scale
proposed by Janin et al. [10]. The importance of the
accessibility information is widely reported in the literature;
the hypothesis is that an accessible site is likely to be recognized
by the antibodies [25,30–32].
3. The hydrophilicity was computed following the scale proposed
by Parker et al. [11]. This scale was recently found to have
slightly better results than the other ones [2,33]. The hypothesis
Prediction of Peptide Reactivity
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so they are probably hydrophilic [5,11].
4. The flexibility was calculated with the scale proposed by
Bhaskaran et al. [12]. A high flexibility of the structure is
hypothesized to favor the propensity of a peptide to bind the
antibodies [34–35].
5. The beta-turn prediction was calculated by exploiting an
amino acid scale of propensities following the Chou-Fasman
method [2,8,13].
The five attributes described above were computed on the basis
of the correspondent amino acid scale, computing the maximum
value within a sliding window of 9 residues. The size of the sliding
window was chosen because it is known that the binding site
covered by an antibody typically includes a stretch of 8 to 10
amino acids [36–37].
The second set of features has been generated taking into
account the entire training set. To obtain such features, every
peptide was aligned with all the others by both the Needleman-
Wunsch algorithm (global alignment) and the Smith-Waterman
algorithm (local alignment) [38–39]. In this way, a scoring matrix
[13638613638] has been computed. In this way, we have
generated a set of additional features, as follows:
1. Global alignment. For every peptide we computed: the
maximum score obtained by the global alignment with every
negative peptides (MaxScore0_nw); the maximum score
obtained by the alignment against the positive set (MaxScor-
e1_nw); the difference between MaxScore1_nw and MaxScor-
e0_nw (DiffMaxScore_nw).
2. Local alignment. For every peptide we considered the
maximum score of the local alignment with the elements of
the positive set and with the elements of the negative set
(MaxScore0_sw, MaxScore1_sw), and the difference between
these maximum values, as well (DiffMaxScore_sw).
The rationale for selecting the features mentioned above is
related to the so-called classification for homology (sequence
similarity), which consists of classifying a sequence (in terms of
structure and function) looking at the most similar sequence in a
dataset of available sequences [40–41]. The principle is that
similar sequences have similar structures and, thus, similar
functions (in this case similar reactivities to antibodies) [42].
In our case, for example, a peptide has a high value of
MaxScore0_nw, if the negative examples contain at least another
very similar peptide. Moreover, the MaxScore feature is used to
check the importance of the absolute value of a good alignment,
while the DiffMaxScore attribute takes into account the difference
between class groups.
It is important to notice that the use of the information about
the class (i.e. positive or negative example) during the feature
generation phase requires to properly designing the cross-
validation phase in order to avoid overfitting.
Finally, the two types of alignments have been used to
understand whether the reactivity depends on the entire sequence
of the peptide (global alignment) or on a small portion (local
alignment), as hypothesized.
Feature selection. Because the training set was made of
13638 examples and the generated features were 37, a features
selection step was not mandatory. However, we decided to filter
the features to obtain a more parsimonious model. We resorted to
a filtering strategy because the use of wrapper methods would have
made the cross-validation approaches (and in particular the leave-
one-out strategy) computationally very demanding. We have
applied three different procedures for feature selection, thus
obtaining three different subsets of features.
N Subset A. No feature selection - the 37 features generated so far
are used.
N Subset B. Feature selection with the M5 method [43–44]; before
applying this approach, all the collinear attributes have been
eliminated.
N Subset C. Feature selection with the LASSO method (least
absolute shrinkage and selection operator) [45].
Cross-validation of the classifiers. As mentioned above,
the final aim of this challenge is to discover whether there exist rules
that enable to predict that a peptide/epitope sequence is recognized
by human antibodies. For this reason, we mainly considered
classifiers that provide a predictive model easy to be interpreted.
N Linear regression. Even if linear regression is a simplistic model
due to its strong assumptions, it gives the possibility to evaluate
the contribution of each single variable to classification. The
outcome variable we considered is the reactivity value, which
ranges from 1 to 65536. The distribution of these values shows
that the outcome can be easily binarized: in fact, as previously
mentioned, the reactivity of the positive peptides ranges
between 10000 and 65536, while this value ranges from 1 to
1000 in the negative peptide case. For this reason, we also
tested this classifier by considering the binary classes 0-negative
and 1-positive as continuous values.
N Logistic regression. Also this approach allows assessing the
contribution of each variable to classification: in fact, the
Table 1. Five amino acid scales used for the features
construction.
Antigenicity Accessibility Hydrophilicity Flexibility Beta-turn
A 1.064 6.6 2.10 0.36 0.66
C 1.412 0.9 1.40 0.35 1.19
D 0.866 7.7 10.00 0.51 1.46
E 0.851 5.7 7.80 0.50 0.74
F 1.091 2.4 29.20 0.31 0.60
G 0.874 6.7 5.70 0.54 1.56
H 1.105 2.5 2.10 0.32 0.95
I 1.152 2.8 28.00 0.46 0.47
K 0.930 10.3 5.70 0.47 1.01
L 1.250 4.8 29.20 0.37 0.59
M 0.826 1.0 24.20 0.30 0.60
N 0.776 6.7 7.00 0.46 1.56
P 1.064 4.8 2.10 0.51 1.52
Q 1.015 5.2 6.00 0.49 0.98
R 0.873 4.5 4.20 0.53 0.95
S 1.012 9.4 6.50 0.51 1.43
T 0.909 7.0 5.20 0.44 0.96
V 1.383 4.5 23.70 0.39 0.50
W 0.893 1.4 210.00 0.31 0.96
Y 1.161 5.1 21.90 0.42 1.14
Columns 2–6 report five of the most promising amino acid properties for
predicting the peptide reactivity: antigenicity [9], accessibility [10],
hydrophilicity [11], flexibility [12] and predicted beta-turn propensity [13].
doi:10.1371/journal.pone.0023616.t001
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evaluate the reliability of the model. Moreover there are no
assumptions about the probability distribution of the attributes.
However, in the model that we have exploited we supposed
that they were not strongly correlated.
N Naı ¨ve Bayes. It is a simple probabilistic classifier based on the
Bayes’ theorem under the attribute independence assumption,
given the class [46]. The model allows an easy interpretation of
the results, since each variable can be separately considered.
The main limits of this approach are the strong assumptions of
conditional independence between variables and the need of
choosing prior distributions.
N Decision tree. This method has the great ability to learn complex
and non-linear relationships between variables and outcome.
Decision trees, however, require the implementation of careful
strategies in order to avoid overfitting. In particular, we used
the J48 algorithm, an open source Java implementation of the
C4.5 method [47]; the dimension of the tree was limited by
fixing the minimum number of instances for each leaf equals to
1% of the training set.
N Rules learner. This method permits, like decision trees, to extract
complex rules; however the accuracy of the predictions is high
only if the rules have a sufficiently large support. Moreover, it
can be computationally demanding in case of large datasets. In
this work we applied the PART method to generate a decision
list. Such method is based on an iterative strategy. In each step,
PART builds a partial decision tree and converts the best leaf
into a rule [48]. The minimum number of instances for each
leaf was fixed at 1% of the examples in order to limit the
number of generated rules.
To evaluate the best classifier, the performances have been
assessed applying the so-called ‘‘leave-one-out’’ cross-validation
approach. This approach is particularly suited in our case, since,
together with maximizing the size of the training set, it allows to
properly generating the features related to the alignment scores.
Choice of final model and its interpretation. The model
was assessed not only in terms of its predictive performance but
also taking into account its interpretation, i.e. by considering the
contribution of the different features included in the prediction.
Together with standard performance measures, such as
accuracy, sensitivity and specificity, we also computed the F-
measure of the predictive model. The F-measure is the harmonic
mean of precision (positive predictive value) and recall/sensitivity.
As a matter of fact, in order to develop a model that is useful to
generate new reactive peptides, it is important to maximize both
precision and sensitivity: it means to have a high probability that
the peptide predicted to be positive is really reactive and that the
reactive peptides are correctly classified.
As previously mentioned, we decided to select, among the best
classifiers, the model with the clearest interpretation. In the case of
logistic regression, we evaluated the reliability of the regression
coefficients by comparing their values and signs with what was
expected in the light of the available knowledge.
Evaluation of the model and of the teams in the DREAM 5
challenge. As mentioned in the previous sections, the classifiers
have been trained on the entire training set. The selected model was
then applied on the test set (3421 positive and 10219 negative
peptides).
The predictions of all the participants to this DREAM5
challenge have been evaluated and compared. Teams were
ranked according to their performance score based on two
metrics: the area under the precision versus recall (PR) curve and
the area under the receiver operating characteristic (ROC) curve.
P-value was defined as the probability that a given or larger area
under the curve value is obtained by a random prediction. The
overall final score was defined as minus the logarithm of the
geometric mean of the ROC and PR p-values.
Bonus round
The final aim of this challenge is to discover whether there exist
rules able to predict reactivity of peptides with human antibodies.
These rules can be used to develop new reactive peptides. The
‘‘bonus round’’ was conceived to test the rules learned during the
main challenge: each team was required to submit a list of de-novo
peptides generated using their predictive models; the list generated by
the teams that achieved the top performance in the main challenge
will be experimentally validated by the DREAM5 organizers.
In particular, the bonus round challenge required the provided
list to contain peptides with sequence length equal to 15, which
must follow these specifications:
N at least 1000 peptides in the list should be predicted to have
high reactivity, i.e. they should be as reactive as the peptides in
the positive training set (high reactivity - H);
N at least 1000 peptides in the list should be predicted to have
low reactivity, as the peptides in the negative training set (low
reactivity - L);
N at least 1000 peptides in the list should be predicted to have
reactivity values in between those of the positive and negative
sets (medium reactivity - M).
Moreover, in order to ensure that the peptides of the generated
list are different from the peptides of the training and test sets, the
following conditions must hold:
1. All submitted peptide sequences should not have stretches of
more than three amino acids in common with any of the amino
acid sequences supplied in the training or test set.
2. The overall identity between any peptide sequence of the
predicted peptides and the training set should not be higher
than 5 within a stretch of 11 amino acid positions.
In summary, the final output of the bonus round should be a list
of 1000 peptides for each of the three classes (i.e. H, L and M). In
the next paragraph we describe the procedure we implemented to
generate such a list. The main idea is to generate de-novo peptides
by extracting from the training set the motifs that characterize the
epitope. A schematic representation of the implemented procedure
is shown in Figure 1.
Clustering. The first step of our strategy is to obtain clusters
of similar peptides. In particular we exploited the scoring matrix
computed by aligning every sequence with all the others with the
Smith-Waterman algorithm (local alignment). We chose local
alignment because the results of the main challenge showed that it
has higher predictive performance than the global one (see
Results). We obtained a distance matrix by subtracting each
element of the normalized scoring matrix to one. Then, we applied
hierarchical clustering with complete linkage and we used a cut-off
value equal to 0.7 to generate the clusters.
Cluster selection and multiple-alignment. We selected
three types of clusters by exploiting the information about the
peptides reactivity.
1) Positive clusters (H) - The clusters with at least five sequences
and where all the members are positives.
2) Negative clusters (L) - The clusters with at least eight
sequences and where all the members are negative.
Prediction of Peptide Reactivity
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sequences and where the percentage of positive members is
similar to the proportion of positive peptides in the training
set (3240/13638=25%).
A multiple-alignment was then performed on the sequences of
each cluster. Thanks to this strategy it was possible to compute the
conservation of each amino acid in a specific position.
Extraction of the motifs in a cluster. We generated a motif
for every sequence 15 amino acids long and belonging to each
cluster/multiple-alignment. In detail, we considered all the amino
acids composing each of these sequences ordered by the
conservation in the corresponding multiple-alignment (computed
in terms of information as shown in Figure 2). A residue was kept
as constant in the motif if it satisfied the first constraint of the
bonus round (no more than three consecutive amino acids already
present in the training set). The remaining amino acids are less
conserved and do not satisfy the constraint of the bonus round; so
these residues were allowed to vary within their amino acid group
or following the variation patterns in a specific position reported in
the multiple-alignment results. The amino acids groups were
obtained by clustering amino acids on the basis of the
BLOSUM50 matrix. A motif was thus generated for every
sequence in the clusters.
Generation of all the possible peptides and selection
based on final model. All the possible sequences have been
generated starting from the motifs extracted with the method
described in the previous paragraph. Such new sequences were
then filtered in accordance with the second constraint of the bonus
round (identity with the other sequences not higher than 5 amino
acids in a window of 11).
The predictive model used in the main challenge (model B) was
exploited to predict the reactivities of the remaining new peptides.
This prediction has been used to rank the new peptides in terms of
predicted reactivity.
We selected the 1100 peptides with the highest predicted
reactivity generated from the positive clusters and the 1100 with
lowest predicted reactivity obtained from the negative clusters.




Feature selection. As described in the previous section, we
generated 37 features to predict peptide reactivity to human
antibodies. We applied three different procedures for feature
selection: no selection (subset A), selection based on collinear
attribute elimination and on the M5 method and (subset B) and
selection based on the LASSO method (subset C). The subset B
and C contain 28 and 27 remaining attributes, respectively. The
subsets B and C are partially different (see Table 2).
Cross-validation of the classifiers. As explained in the
Methods section, we learned five different classifiers on the three
features subsets. Cross-validation was performed with a leave-one-
out approach. The models obtained by applying decision tree and
rules learner are reported in the supplementary material (see Text
S1 and Text S2).
Table 3 shows the results obtained in terms of mean accuracy,
sensitivity, specificity, precision and F-measure:
N The results of the classifiers are in general quite good. This
shows that the generated features contain useful information to
predict the peptide reactivity.
N The imbalance between the number of positive and negative
examples in the training set (3420 positives and 10218
negatives) partially influences the results: the sensitivity is
always lower than the specificity.
Figure 1. A schematic representation of the procedure for bonus round. The schema shows the principal steps implemented for generating
the list of de-novo peptides with low (L), medium (M) and high (H) reactivity: (i) clustering of peptides based on the matrix of distances, (ii) cluster
selection and multi-alignment, (iii) creation of some motifs for each sequence in a cluster, (iv) generation of all the possible peptides (followed by the
final selection of the peptides based on final model).
doi:10.1371/journal.pone.0023616.g001
Figure 2. Two examples of peptide clusters. The figure shows two
examples of a positive cluster (top) and a negative cluster (bottom).
Each cluster of peptide is described by its multiple alignments (on the
right top of each sub-figure) and by its representation through
sequence logo [49]. This graphical representation displays the
conservation of the amino acids in each position of the multi-alignment
by their one-letter code. Different residues at the same position are
scaled according to their frequency. In particular the height of the
entire stack of residues is the information measured in bits (y-axis).
doi:10.1371/journal.pone.0023616.g002
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performance, even if the difference between the results of the
different classifiers is not statistically significant.
N We tested linear regression by both considering discrete or
continuous outcomes. This first alternative always gave the
best results.
N The best results are obtained after feature selection (subset B
and C). This shows that some redundant information is present
in the original set of features.
N In terms of F-measure, the logistic regression had a
performance clearly higher than all the others (71.15% and
71.17% on subset B and C, respectively). Moreover,
considering the quality of the learned models in terms of their
Brier Score, the following results were achieved: Lin.Reg.
(reactivity) 0.1412; Lin.Reg. (binary) 0.14249; Log. Reg.
0.10344; Naive Bayes 0.13309; Decision tree 0.13717; Rules
learner 0.14258. The model based on logistic regression
reached the best results, giving a further demonstration of its
robustness.
Choice of the final model. The logistic regression models
obtained by considering feature subsets B and C have been
evaluated in terms of their explanation capabilities.
First of all, we analyzed the two subsets of features by giving
some explanations about the removed attributes (zeros are
assigned to removed attributes in Table 2, columns 4 and 5).
N By calculating the correlation among the features along the
examples and also among the amino-scales used, we found that
accessibility, flexibility and hydrophilicity were quite correlated.
This is probably the reason why only flexibility was selected in
subset B while only hydrophilicity was kept in subset C.
N Concerning the features derived from the alignments,
DiffMaxScore attributes were based on MaxScore features,
so they are functionally related. The DiffMaxScore feature was
removed in subset B because it did not bring any additional
information.
N Moreover in subset B all the features derived from global
alignment have been removed, suggesting, as expected, that
the reactivity depends on a small portion of the peptide, which
probably corresponds to the binding site (information retrieved
by local alignment). Also in the case of subset C, two out of the
three remaining alignment-based features have been derived
from local alignment.
N As the amino acid frequencies are concerned, the attributes
associated to the presence of X, B and J are present in both
subsets B and C, since few sequences contain such residues.
The features related to Alanine and Isoleucine have been
removed only from subset C.
We then analyzed the estimated coefficients of the logistic
regressions in order to further investigate which was the most
reliable between the two models. In particular, the estimated
coefficients of both models are reported in Table 2, columns 4 and
5. These coefficients have been evaluated on the basis of the
available knowledge but also on the basis of the correlation of each
feature with the class, as computed in the training set (Single
Regression Coefficients - SRCs). The second column of Table 2
reports the regression coefficient computed for each attribute,
while column 3 reports its F-measure.
N Every SRC corresponding to an alignment-based feature has
the expected sign, given its definition: SRCs are negative for
MaxScore_0 and DiffMaxScore features, while they are
positive for MaxScore_1. This is confirmed by the corre-
sponding values of the regression coefficients for model B (see
Table 2 at column 4). However, model C has an unexpected
negative value related to MaxScore_1_nw (see Table 2 at
column 5)., Both models confirm that local alignment is more
useful for classification than global alignment.
Table 2. The impact on the predictive performance of the
features and the coefficients of the two best models.
SRCs F-measure Log.Reg. B Log.Reg. C
LengthSeq 0.51 41.0% 4.75 26.97
Isoel. point 0.24 33.2% 0.78 0.13
A 20.44 37.1% 7.62 0.00
C 0.37 40.1% 6.05 0.77
D 20.25 36.2% 5.79 2.33
E 20.98 41.1% 7.40 0.28
F 0.91 45.7% 9.43 21.91
G 0.00 30.3% 8.24 4.35
H 0.52 35.2% 8.74 1.49
I 20.04 33.5% 3.48 0.00
K 20.17 34.3% 6.52 2.07
L 0.13 31.6% 9.17 0.22
M 0.35 35.2% 5.74 2.09
N 20.19 36.9% 3.11 2.08
P 20.26 34.3% 7.01 20.46
Q 20.43 38.9% 3.17 0.11
R 0.45 40.5% 7.78 21.56
S 20.51 33.1% 8.00 2.59
T 20.20 34.3% 4.72 20.25
V 20.11 33.9% 3.77 20.18
W 0.94 40.1% 8.78 20.43
Y 1.44 51.0% 11.51 4.49
B 0.00 - 0.00 0.00
X 0.75 40.1% 0.00 0.00
J 0.00 - 0.00 0.00
Z 20.66 40.9% 24.55 6.50
Antigenicity 0.49 31.6% 1.62 21.13
Accessibility 20.85 40.8% 0.00 0.00
Hydrophilicity 20.71 42.6% 0.00 20.35
Flexibility 20.78 38.9% 1.26 0.00
Beta-turn 20.26 27.0% 20.92 1.66
MaxScore0_nw 20.54 38.8% 0.00 0.00
MaxScore1_nw 1.36 45.7% 0.00 26.66
MaxScore0_sw 20.53 37.9% 23.96 0.00
MaxScore1_sw 1.17 52.5% 4.32 0.81
DiffMaxScore_nw 21.35 53.1% 0.00 0.00
DiffMaxScore_sw 21.28 58.9% 0.00 20.61
Intercept 215.76 4.73
The second column shows the correlation coefficients of each feature with the
class calculated on the training set (single regression coefficients - SRCs). The
third column reports the F-measure values of the single attributes. Columns 4
and 5 display the estimated coefficients of the two best models: logistic
regression on subset B and logistic regression on subset C; zero values
correspond to removed features.
doi:10.1371/journal.pone.0023616.t002
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positive SRC, as expected. All the other scale-based features
have negative SRCs; as a matter of fact, it is known that
accessibility, hydrophilicity and flexibility have negative
correlations with the reactivity, while it is more difficult to
interpret the negative correlation of beta-turn propensity.
Both model B and C include only three scale-based features.
Given the SRCs and their plausible explanations, both models
have only an unexpected regression coefficient, in correspon-
dence of flexibility (model B) and antigenicity (model C).
N No well-defined knowledge is available about the influence of
the amino acid frequencies on the peptide reactivity. So, we
assessed the correlation of the corresponding SRCs with the
different amino acid scales (antigenicity: 0.29; accessibility:
20.66; hydrophilicity: 20.69; flexibility: 20.52; beta-turn
propensity: 20.19). The sign of the correlations (i.e. Spearman
correlation) follows the same pattern of the scale-based
features: all the features are negatively correlated with peptide
reactivity except for antigenicity.
Finally, we evaluated the reliability of the regression
coefficients of the multivariate model in terms of their
correlation with the SRCs. Model B showed a good positive
correlation between the regression coefficients and the
correspondent SRCs (i.e. Spearman correlation=0.496 and
p-value=0.028), while in model C no correlation was found
(i.e. Spearman correlation=20.075 and p-value=0.753).
Based on all these considerations, we selected model B as the
best final model, even if model C had a higher F-measure.
Evaluation of the model. The selected model was used to
generate predictions on the test set data (3421 positive and 10219
Table 4. Scores of the participants to DREAM5 challenge 1.
Team AUPR AUROC Pval AUPR Pval AUROC Score
Team 725 0.772 0.893 2.05E-23 4.75E-19 20.51
Log. Reg. B 0.768 0.895 3.20E-22 1.00E-19 20.25
Log. Reg. C 0.767 0.894 4.11E-22 1.48E-19 20.11
Team 161 0.691 0.864 4.08E-06 1.26E-08 6.64
Team 763 0.689 0.855 6.56E-06 4.02E-06 5.29
Team 795 0.678 0.850 1.76E-04 4.91E-05 4.03
Team 852 0.663 0.849 5.92E-03 9.20E-05 3.13
Team 730 0.662 0.846 6.59E-03 3.86E-04 2.80
Team 809 0.636 0.846 2.79E-01 3.46E-04 2.01
Team 834 0.597 0.835 9.89E-01 1.85E-02 0.87
Team 433 0.627 0.803 5.71E-01 9.85E-01 0.13
Team 703 0.596 0.813 9.91E-01 8.19E-01 0.05
Team 811 0.604 0.748 9.70E-01 1.00E+00 0.01
Team 528 0.565 0.790 1.00E+00 1.00E+00 0.00
Team 550 0.355 0.612 1.00E+00 1.00E+00 0.00
Team 737 0.582 0.793 9.99E-01 9.99E-01 0.00
The table shows the performance of all the participants to DREAM5 challenge 1.
Columns 2–5 displays the Area under the Precision-Recall curve (AUPR), the
Area under the ROC curve (AUROC), the p-value of AUPR (Pval AUPR) and p-
value of (Pval AUROC), respectively. All the participants are evaluated in terms
of the final overall score (reported in column 6); it was defined as minus the
logarithm of the geometric mean of Pval AUROC and Pval AUPR. The results of
our two best models are highlighted in bold.
doi:10.1371/journal.pone.0023616.t004
Table 3. Results of the classifiers evaluated by leave-one-out cross-validation.
Features Classifiers Acc Sens Spec Prec F-measure
Subset A Lin.Reg. reactivity 85.01% 70.12% 90.00% 70.12% 70.12%
Lin.Reg. 85.21% 70.64% 90.09% 70.46% 70.55%
Log. Reg. 85.15% 70.41% 90.09% 70.39% 70.40%
Naive Bayes 83.84% 67.81% 89.21% 67.77% 67.79%
Decision tree (J48) 81.32% 64.56% 86.94% 62.32% 63.42%
Ruleslearner(PART) 80.75% 63.22% 86.61% 61.25% 62.22%
Subset B Lin.Reg. reactivity 84.92% 69.94% 89.94% 69.94% 69.94%
Lin.Reg. 85.17% 70.47% 90.10% 70.43% 70.45%
Log. Reg. 85.51% 71.23% 90.29% 71.06% 71.15%
Naive Bayes 83.47% 67.08% 88.96% 67.04% 67.06%
Decision tree (J48) 81.40% 63.71% 87.32% 62.71% 63.21%
Ruleslearner(PART) 77.64% 57.43% 84.40% 55.20% 56.29%
Subset C Lin.Reg. reactivity 84.95% 70.00% 89.96% 70.00% 70.00%
Lin.Reg. 85.19% 70.59% 90.08% 70.42% 70.50%
Log. Reg. 85.54% 71.17% 90.35% 71.17% 71.17%
Naive Bayes 83.02% 66.14% 88.67% 66.14% 66.14%
Decision tree (J48) 81.42% 65.50% 86.75% 62.33% 63.87%
Ruleslearner(PART) 81.47% 63.28% 87.56% 63.00% 63.14%
The table shows the results of the six classifiers evaluated by leave-one-out cross-validation on three different subsets of features (A, B and C): (i) linear regression
considering the reactivity values; (ii) linear regression considering the binary classes 0-negative and 1-positive as continuous values; (iii) logistic regression; (iv) Naı ¨ve
Bayes; (v) decision tree; (vi) rules learner. The second column displays the name of the tested classifiers. Columns 3–7 report the results reached by each classifier in
terms of mean accuracy (Acc), sensitivity (Sens), specificity (Spec), precision (Prec) and F-measure ((2*Sens*Prec)/(Sens+Prec)). The two models with highest F-measure
are highlighted in bold.
doi:10.1371/journal.pone.0023616.t003
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other participants to DREAM5 challenge 1, were evaluated in
terms of a score based on the area under the precision versus recall
(PR) curve and the area under the receiver operating characteristic
(ROC) curve.
The results obtained by Model B and Model C are reported in
Table 4. Both models had a very high performance in terms of PR
and ROC, as shows in Figure 3. It is important to note that Model
B achieved the highest score.
By analyzing the scores of all the participants, reported in
Table 4, it can be noted that two teams (our team and team 725)
clearly over-performed all the others.
Bonus round
As explained in the previous section, the final output of the
bonus round is a list of 1000 new peptide sequences for each of the
three classes: high reactivity (H), low reactivity (L) and medium
reactivity (M).
The procedure for the generation of these peptides follows the
steps described in the Methods section and schematically reported
in Figure 1.
In the first phase we used the scores of local alignment to cluster
the available sequences. As result of this first phase, about 7000
clusters with different size have been created.
Then we exploited the class information to select three types of
clusters. By applying the rules described in the Methods section,
we selected 23 positive clusters, 27 negative clusters and 4
uncertain clusters. An example of positive cluster and an example
of negative one are shown in Figure 2: the figure depicts the
multiple alignments of the two clusters and their representation
through sequence logos [49].
The motif generation phase resulted in a few thousands
sequences for each class group (i.e. H, L and M).
Finally, we computed the predicted reactivity for all the
sequences generated from the positive and negative clusters. The
final list was formed by: i) the 1100 peptides with the highest
predicted reactivity generated from the positive clusters, ii) the
1100 with lowest predicted reactivity from the negative clusters
and iii) 1100 peptides randomly selected from the uncertain
clusters. As shown in Figure 4, the distributions of the predicted
reactivity clearly separate the peptides coming from the positive
clusters and the negative ones. This demonstrates the validity of
the strategy adopted to generate new peptides.
The experimental test of the real reactivity of these peptide
sequences is still ongoing.
Discussion
In the present work we described the procedure implemented to
cope with the Epitope-Antibody Recognition (EAR) Specificity
Prediction Challenge of the DREAM5 competition. The aim of
the EAR challenge was to extract rules able to predict the binding
Figure 3. ROC curve and Precision-Recall curve of the two best final models. The figure displays the ROC curve (top) and the Precision-
Recall curve (P-R) (below) calculated for the two best final models: logistic regressions fitted on the features contained in the subset B (model B) and
in the subset C (model C).
doi:10.1371/journal.pone.0023616.g003
Prediction of Peptide Reactivity
PLoS ONE | www.plosone.org 9 August 2011 | Volume 6 | Issue 8 | e23616of a peptide/epitope to a human antibody. A training set of
peptides with experimentally identified high and low reactivity to
human antibodies was provided. The challenge consists therefore
in determining whether the peptides of an independent test set
belong to the positive or negative set.
As mentioned in the previous section, we have exploited a
machine learning approach to analyze the data, after a knowledge-
based feature generation phase. In particular we extracted two
types of features for every peptide: (i) sequence-dependent features,
which are based on both general information about peptides and
knowledge about the propensity of a peptide to interact (amino
acid frequencies, antigenicity, accessibility, etc.); (ii) dataset-
dependent features, which are generated by exploiting the scores
obtained by aligning every peptide of the training set with all the
others with both global and local alignment. A total of 37 features
have been finally generated.
We considered three different subsets of such attributes, based
on different feature selection strategies. As a last step, we learned
some simple classifiers, which have been evaluated with a leave-
one-out cross-validation approach. Since the final aim of the EAR
challenge is to extract rules able to explain the propensity of
peptide to react, we selected classifiers able to provide a model
easy to be interpreted (e.g. logistic regression, rule learners,
decision trees, etc.).
The classifier finally selected was built with the logistic
regression, one of the most widely used classifiers, able to predict
the probability of the class on the basis of both continuous and
discrete features. The best results were achieved by using a
reduced subset of features; in particular, taking into account the
model interpretation needs, we selected the logistic regression
fitted with the features obtained by M5 method.
The evaluation of the prediction of the model on the test set
showed the validity of the approach: the model had one of the best
performances of the challenge. As a note, the performances of the
model on the test set are higher than the one obtained with cross-
validation on the training set (e.g. F-measure metrics are 71.26%
and 71.15%, respectively).
In general, this good performance has demonstrated that, even
if the prediction of epitope reactivity is a difficult problem, there
are ways to obtain promising predictive models based on the
combination of prior knowledge and data analysis [50].
Together with the high performance of the proposed reactivity
prediction model, the present work highlights some open issues
concerning the propensity of a peptide to react with human
antibodies.
N The features based on local alignment are more predictive
than the ones based on global alignment. This shows that, as
expected, the reactivity depends on a small portion of the
peptide, which probably corresponds to the binding site.
N In contrast to some hypotheses previously formulated, the
features related to accessibility, flexibility and hydrophilicity
are negatively correlated with the reactivity values of the
dataset.
Concerning accessibility and hydrophilicity, the hypothesis
that the antigenic sites are on the surface, and thus probably
hydrophilic, was recently confuted [9]. As a matter of fact, the
analysis of the experimentally determined antigenic sites has
revealed that the hydrophobic residues are more likely to be a
part of antigenic sites if they occur on the surface of a protein.
Moreover, some studies hypothesized that the flexibility is
inversely proportional to antigenic propensity [9,51]: a
relatively high positive correlation (i.e. Spearman correla-
tion=0.61 and p-value=0.018) was found between the
flexibility and the minimum concentration needed to inhibit
the E.Coli growth with antimicrobial peptides. As a matter of
fact, a small flexibility may be related to a compact structure,
which could favor antigenic propensity.
Figure 4. The distributions of the predicted reactivities of bonus round peptides. We selected the same number of peptides (i.e. 1100)
both deriving from negative and from positive clusters. The reactivity of the peptides of the two groups is predicted through the final best model
proposed for the main challenge. This figure shows the histogram of such predicted reactivities. In particular we considered the binary classes 0-
negative (reactivity between 1 and 1000) and 1-positive (reactivity between 10000 and 65536); the predicted reactivity of a peptide in the range [0:1]
is given by the probability to belong to the positive class.
doi:10.1371/journal.pone.0023616.g004
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This result confirms the appropriateness of the scale used for
its calculation [9]: this is defined as the ratio between the
frequency of the residue in antigenic determinants (experi-
mentally identified) and the frequency of the amino acid on the
surface (predicted by using the average of hydrophilicity,
accessibility and flexibility values reported by Parker et al.
[11]).
N F i n a l l y ,t h eh i g hv a l u e so fb o t hS R C sa n dr e g r e s s i o n
coefficients, as shown in Table 2 (see columns 2 and 4),
demonstrate that some amino acids, like F and Y, favour the
peptide reactivity.
The future developments of this work will concern the test of
our model on other datasets related to the prediction of epitope
reactivity. Preliminary encouraging results have been achieved on
some peptides of the IEDB (Immune Epitope DataBase) [52].
The final aim of the challenge was to elucidate the mechanisms
of epitope reactivity with human antibodies; for this reason, a
‘‘bonus round’’ was proposed beside this main challenge. To this
end, we have developed a method based on a clustering approach.
We grouped the peptides of the training set in about 7000 clusters
by using as distance the score of the local alignment. Then, we
selected 23 positive, 27 negative and only 4 uncertain clusters by
a-posteriori taking into account of the class of the peptides. It is
worthwhile mentioning that the small number of negative and
positive clusters demostrates that there are many rules underlying
peptide reactivity. Each rule has thus a small support; this is
probably related to the wide variability of the antibodies.
The clusters have been used to extract a set of motifs that were
the basis to generate an initial list of potential new peptides. We
predicted the reactivity of such new peptides relying on our model:
the sequences with highest and lowest predicted reactivity formed
the final list of de-novo peptides. The results of the experimental
test of the real reactivity of these peptide sequences will be
available in the near future.
Supporting Information
Text S1 J48 pruned tree learned on the entire training
set starting from the features subset B.
(DOC)
Text S2 PART decision list learned on the entire
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